Extended Leukemia/Lymphoma Panel - 31 markers
Use
The Extended Leukemia/Lymphoma Panel is utilized to evaluate patients with suspected leukemia or lymphoma. This test assesses a variety of markers to aid in the diagnosis, prognosis, and monitoring of these hematological malignancies, providing critical information for treatment planning.
Special Instructions
Not provided.
Limitations
Results may be affected by specimen degradation if not properly maintained. Specimen viability is crucial for accurate results, and improper collection methods or delays in transport may impact overall test accuracy.
New York Approved
Methodology
Cell-based / Cytometry (Flow Cytometry)
Biomarkers
Result Turnaround Time
24 hours
Related Documents
For more information, please review the documents below
Specimen
Bone Marrow
Volume
1-2 mL
Minimum Volume
Not provided
Container
EDTA, Sodium heparin
Collection Instructions
Include a recent CBC report.
Storage Instructions
Refrigerate specimen. Do not freeze.
Causes for Rejection
Lithium heparin or ACD (pale yellow/no gel separator) is not acceptable.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 72 hours |